Skip to content

Pulse Biosciences, Inc Common Stock (DE) (PLSE) — WACC Analysis

WACC Breakdown

Pulse Biosciences, Inc Common Stock (DE) (PLSE) has a weighted average cost of capital (WACC) of 10.6%. The cost of equity is 10.6%, derived from a beta of 1.41 and a risk-free rate of 5.2%. The after-tax cost of debt is 5.0%. The capital structure is 100.0% equity and 0.0% debt.

Interpretation

A WACC of 10.6% is moderate, reflecting the market's balanced risk assessment of Pulse Biosciences, Inc Common Stock (DE).

Investors can compare PLSE's WACC of 10.6% against industry peers to gauge its relative financing costs. A beta of 1.41 reflects the stock's volatility relative to the broader market.

DeepViews
VALUATION

PLSE WACC: 10.61% for Pulse Biosciences, Inc Common Stock (DE)

Current inputs imply a 10.61% cost of equity and a 5.00% pre-tax cost of debt. Use this discount rate as a starting point for DCF validation.

[01]Current Market Data
Loading market data...
[02]
WACC Calculation Process
1
Market Data Loaded
2
Company Data Fetched
3
Beta Calculated (5Y)
4
Inputs Auto-Populated
5
WACC Calculated
[03]
Step 2: Enter Ticker Symbol
Quick search:
Step 4: Review Auto-Populated WACC Inputs

Values are automatically populated from real data. You can adjust them manually if needed.

4.30%
1.000
4.23%
5.00%
21.00%
70.00%
Debt: 30.00%Equity: 70.00%

Please enter a valid company ticker to calculate WACC

Pulse Biosciences, Inc Common Stock (DE) Common Stock (PLSE) WACC Results
Weighted Average Cost of Capital
10.61%
Cost of Equity
10.61%
Risk-Free Rate5.22%
Beta1.41
Market Risk Premium4.23%
Cost of Debt
5.00%
Pre-Tax Cost of Debt5.00%
Tax Rate0.00%
Tax Shield0.00%
Capital Structure
Equity: 100.00%($3740.87M)
Debt: 0.00%($0.00M)
Equity Component
10.61%
100.00% × 10.61%
Debt Component
0.00%
0.00% × 5.00%

Pulse Biosciences, Inc Common Stock (DE) (PLSE) WACC in context

Pulse Biosciences, Inc Common Stock (DE) (PLSE) currently screens with an estimated WACC of 10.61%. That blends a 10.61% cost of equity, a 5.00% pre-tax cost of debt, and a 100.00% equity weight into the discount rate you would typically use in a DCF model.

falls into a common range for established public companies and is a practical DCF starting point.

What PLSE WACC implies

A 10.61% discount rate falls into a common range for established public companies and is a practical DCF starting point.

How this page calculates PLSE

This page combines CAPM-based cost of equity with SEC-derived debt and capital structure inputs. The current beta is 1.41 and equity accounts for 100.00% of capital.

What to do next

Validate business quality on the company page, then carry the same discount-rate assumptions into the DCF page to test fair value sensitivity.

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.

PLSE WACC: 10.61% — Pulse Biosciences, Inc Common Stock (DE) Cost of Capital (October 2026) | DeepViews